NDC 0310-0088-28
Daliresp 250 ug/1
roflumilast · TABLET
Daliresp is a tablet containing roflumilast at a strength of 250 ug/1. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- Daliresp
- Generic Name
- roflumilast
- NDC Code (Package)
0310-0088-28- NDC Code (Product)
0310-0088- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 250 ug/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA022522
- Drug Class
- Phosphodiesterase 4 Inhibitor [EPC]
- Marketing Start
- 07/01/2015
Recall History
No Recall HistoryView Full Drug Page
Daliresp — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.